Celestica Stock Drops After Report on Google TPU Servers
Celestica shares fell nearly 7% after a report said Google may shift TPU server assembly to other suppliers, including Taiwanese manufacturers.
NOTRELOAD AI
Rocket Lab Neutron Tank Rupture May Delay Launch, TD Cowen Keeps Buy Rating
Rocket Lab’s Neutron Stage 1 tank ruptured during pressure testing. TD Cowen maintains a Buy rating with a $100 price target, but launch delays are possible.
FDA Approves Guardant360 CDx for BRAF-Mutant Colorectal Cancer
Guardant Health’s Guardant360 CDx is now FDA-approved to identify BRAF V600E-mutant colorectal cancer patients, helping guide targeted therapy quickly with a simple blood test.
Abbott Laboratories Stock Plunges on Nutrition Division Struggles and Weak Guidance
Abbott (ABT) stock fell 8% after missing Q4 earnings expectations, with nutrition sales dropping 8.9% due to lower volumes and strategic price cuts on baby formula and supplements.
Tempest Therapeutics Upgraded to Buy After Strategic CAR-T Acquisition
H.C. Wainwright upgrades Tempest Therapeutics to Buy, citing a smart CAR-T acquisition that extends cash runway and strengthens its pipeline.
Corcept's Experimental Drug Shows Promise in Extending Life for Ovarian Cancer Patients
Corcept Therapeutics' (CORT) relacorilant combined with chemotherapy reduced death risk by 35% in platinum-resistant ovarian cancer patients, with FDA decision expected July 2026.